Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis releases results of MS drug trials weeks ahead of FDA verdict

May 28, 2020
Business Services MS, Novartis

Novartis has revealed clinical trial data from testing its anti-CD20 leukameia drug Arzerra (ofatumumab) in patients with multiple sclerosis (MS). …

News
bmssyracuseny

BMS’ Zeposia becomes first S1P receptor modulator available in Europe for relapsing remitting multiple sclerosis

May 28, 2020
Sales and Marketing Avonex, Bristol-Myers Squibb, EU, Europe, Zeposia, bristol myers squibb, multiple sclerosis

Bristol Myers Squibb is celebrating after its oral therapy Zeposia (ozanimod), secured European Commission for the treatment of relapsing remitting …

News
black_market

European countries reject hydroxychloroquine treatments for COVID-19

May 28, 2020
Business Services COVID-19, coronavirus, hydroxychloroquine

Multiple European countries have rejected the use of hydroxychloroquine in patients suffering from coronavirus, due to a lack of evidence …

News
malaria_usa

FDA grants marketing approval for US Army’s malaria treatment

May 28, 2020
Business Services Malaria drug, US, US army, US., malaria

The FDA has granted marketing approval for the US Army Medical Research and Development Command’s (USAMRDC) Artesunate for injection, which …

News
martin_andrews

Evox appoints ex-GSK exec Martin Andrews as new non-Executive Director

May 28, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evox, GSK, appointment

Evox Therapeutics has named ex-GlaxoSmithKline executive Martin Andrews as its new non-Executive Director, it has emerged.   Andrews has previously …

Appointment
sergei_svarovsky

Axim Biotechnologies Inc announces Dr Sergei Svarovsky as Chief Scientific Officer of subsidiary Sapphire Biotech

May 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Axim Biotechnologies has announced that Dr Sergei Svarovsky will be the new Chief Scientific Officer of its subsidiary Sapphire Biotech. …

Appointment
fda

FDA approves Sanofi’s Dupixent for children with dermatitis

May 27, 2020
Research and Development Dupixent, Sanofi, atopic eczema

The FDA has approved Sanofi’s Dupixent (dupilumab) for children between ages 6 to 11 with moderate to severe atopic dermatitis. …

News
pharmafocus_june_2020_front_cover

The June 2020 issue of Pharmafocus is available to read free online now!

May 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, coronavirus, data management, pharma, rare disease, treatment access

The latest monthly edition of Pharmafocus, the June 2020 issue, is available to read for free online now! The world remains …

News
cdc_coronavirus

Pharmafile.com’s weekly COVID-19 news round-up

May 27, 2020
Research and Development COVID-19, coronavirus, coronavirus round up

COVID-19 vaccines and treatments continue to dominate the news, as AstraZeneca is attempting to deliver one billion doses of coronavirus …

News

NICE reverses previous stance to recommend Roche’s Tecentriq in extensive-stage small-cell lung cancer

May 27, 2020
Research and Development, Sales and Marketing NICE, Roche, lung cancer, tecentriq

NHS patients with treatment-naïve extensive-stage small-cell lung cancer (ES-SCLC) in England and Wales will soon have access to a new …

News
nhsssssss

Remdesivir available to select COVID-19 patients through the NHS

May 27, 2020
Research and Development coronavirus, covid19

Gilead Sciences Ebola drug remdesivir will be available for selected patients who are suffering from coronavirus through the NHS. The …

News
darren_taylor1

Living with multiple ‘invisible’ conditions

May 26, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, rare disease

Darren Taylor lives with a range of conditions including Dercum’s disease, cystic fibrosis, fibromyalgia with chronic fatigue, and Tietze syndrome, …

Feature
covid-19_vaccine

Scientists working on UK COVID-19 vaccine say there is now only a 50% chance of success due to falling cases

May 26, 2020
Manufacturing and Production COVID-19, coronavirus

Researchers working on a COVID-19 vaccine are facing a race against time due to falling rates of the virus threatening …

News
sonny

Hot and humid weather can slow COVID-19 transmission, new study finds

May 26, 2020
Manufacturing and Production COVID-19, coronavirus

A new study from the Massachusetts Institute of Technology, Harvard, Virginia Tech and the University of Connecticut has shown that …

News
fda

FDA approves Takeda’s first-line treatment option for non-small cell lung cancer

May 26, 2020
Manufacturing and Production FDA, Takeda, approval

The FDA has approved Takeda’s Alunbrig (brigatinib) for adult patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer …

News
49891315508_8849365d96_c

Cleaning staff excluded from GSK’s £1.5k COVID-19 employee bonus

May 26, 2020
Manufacturing and Production COVID-19, GSK, coronavirus, pharma

UK pharma giant GlaxoSmithKline has pledged to pay a cash bonus of £1,500 to staff continuing to work during the …

News
world

WHO stops hydroxychloroquine trial due to safety concerns

May 26, 2020
Manufacturing and Production COVID, COVID-19, coronavirus

The World Health Organization has announced it will stop a global study into the effectiveness of hydroxychloroquine in COVID-19 patients, …

News
4223373030_df7722f9f7_c

Harvard study suggests monkeys develop immunity after receiving COVID-19 vaccines

May 21, 2020
Research and Development COVID-19, vaccine coronavirus

“The COVID-19 pandemic has made the development of a safe, effective, and deployable vaccine a critical global priority”, said researchers …

News
uk_drox

UK begins hydroxychloroquine trial

May 21, 2020
Business Services COVID-19, coronavirus, hydroxychloroquine

A trial investigating the effectiveness of hydroxychloroquine against COVID-19 has begun in the UK. The first participants will be enrolled …

News
hand_washing

Two billion people are at high risk of contracting COVID-19 due to poor sanitation

May 21, 2020
Business Services COVID-19, coronavirus, sanitation

About a quarter of the world’s population are at higher risk of catching the COVID-19 coronavirus due to a lack …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026